Top Section
Top Section
Executive is moving to more senior role
India is on track for a record year of IPOs. Global tech giants continue to plough capital into a fast-growing consumer economy that is investing heavily in ensuring it’s a major player — along with the US and China — in an AI-first world
◆ Deal finds demand despite arrest of South Korea's president ◆ High single digit concession left for investors ◆ Leads added spread to calm concerns
More articles
More articles
More articles
-
Indian pharmaceutical company Strides Shasun Arcolabs has priced a qualified institutional placement — which raised Rp11.03bn ($166.4m) — below its floor price, according to a filing with India’s National Stock Exchange on Monday. -
YiChang HEC ChangJiang Pharmaceutical Co has priced its HK$1.67bn ($215.4m) IPO in the middle of the range, driven by price sensitive investors in the final book.
-
The London Stock Exchange (LSE) is working with Chinese authorities on the possibility of London-listed RMB-denominated shares, most likely in the form of global depositary receipts (GDRs), Jon Edwards, head of primary markets, Greater China, LSE, told GlobalRMB.
-
Shanghai Fosun Pharmaceutical Group is looking to spin off subsidiary Yaneng Bioscience with a listing in Hong Kong, according to a filing with the city’s stock exchange.
-
The central bank of Laos is planning to close its debut offshore syndicated loan at a size of $158m, in a deal that bankers are hailing as a benchmark for other issuers from the country.
-
The Securities and Exchange Board of India has put together a consultation paper for the public issuance of units of infrastructure investment trusts (InvITs), tackling topics ranging from filing an offer document to divvying up stock to potential investors.
shared comment list
